The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation-Reference-Cited by-同舟云学术

The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation

Published:2010-07-29 Issue:5 Volume:52 Page:1680-1689
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lai Jin-Ping,Oseini Abdul M.,Moser Catherine D.,Yu Chunrong,Elsawa Sherine F.,Hu Chunling,Nakamura Ikuo,Han Tao,Aderca Ileana,Isomoto Hajime,Garrity-Park Megan M.,Shire Abdirashid M.,Li Jia,Sanderson Schuyler O.,Adjei Alex A.,Fernandez-Zapico Martin E.,Roberts Lewis R.

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.23848/fullpdf

Reference22 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Hepatocellular carcinoma: molecular pathways and new therapeutic targets;Roberts;Semin Liver Dis,2005

3. Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma;Bengochea;Br J Cancer,2008

4. Wnt/Frizzled signaling in hepatocellular carcinoma;Lee;Front Biosci,2006

5. Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling;Capurro;Cancer Res,2005

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects and mechanisms of N6-methyladenosine RNA methylation in environmental pollutant-induced carcinogenesis;Ecotoxicology and Environmental Safety;2024-06

2. Construction of GPC3-modified Lipopolymer SiRNA Delivery System;Current Pharmaceutical Design;2024-05

3. 6-O-endosulfatases in tumor metastasis: heparan sulfate proteoglycans modification and potential therapeutic targets;American Journal of Cancer Research;2024

4. The prognostic value and immunological role of SULF2 in adrenocortical carcinoma;Heliyon;2023-02

5. Heterogeneity beyond tumor heterogeneity—SULF2 involvement in Wnt/β-catenin signaling activation in a heterogeneous side population of liver cancer cells;BIOCELL;2023